Evidence map›Paper›PMID 32983148›Full record

ArticleFrontiers in immunology2020

Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.

Bárbara Soria-Juan, Natalia Escacena, Vivian Capilla-González, Yolanda Aguilera, Lucía Llanos, Juan R Tejedo, Francisco J Bedoya, Verónica Juan, Antonio De la Cuesta, Rafael Ruiz-Salmerón and 16 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

26 authors at 12 institutions in 2 countries.

Bárbara Soria-JuanFundación Jiménez Díaz Health Research Institute, Madrid, Spain.
Natalia EscacenaDepartment of Regeneration and Cell Therapy, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), University of Pablo de Olavide-University of Seville-CSIC, Seville, Spain.
Vivian Capilla-GonzálezDepartment of Regeneration and Cell Therapy, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), University of Pablo de Olavide-University of Seville-CSIC, Seville, Spain.
Yolanda AguileraDepartment of Regeneration and Cell Therapy, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), University of Pablo de Olavide-University of Seville-CSIC, Seville, Spain.
Lucía LlanosFundación Jiménez Díaz Health Research Institute, Madrid, Spain.
Juan R TejedoDepartment of Regeneration and Cell Therapy, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), University of Pablo de Olavide-University of Seville-CSIC, Seville, Spain.
Francisco J BedoyaDepartment of Regeneration and Cell Therapy, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), University of Pablo de Olavide-University of Seville-CSIC, Seville, Spain.
Verónica JuanAndalusian eHealth Library, Sevilla, Spain.
Antonio De la CuestaUnidad de Isquemia Crónica de Miembros Inferiores, Hospital Victoria Eugenia de la Cruz Roja, Sevilla, Spain.
Rafael Ruiz-SalmerónServicio de Cardiología, Hospital Universitario Virgen Macarena, Sevilla, Spain.
Enrique AndreuClínica Universidad de Navarra, Pamplona, Spain.
Lukas GrochowiczClínica Universidad de Navarra, Pamplona, Spain.
Felipe PrósperClínica Universidad de Navarra, Pamplona, Spain.
Fermín Sánchez-GuijoIBSAL-Hospital Universitario Salamanca, Salamanca, Spain.
Francisco S LozanoIBSAL-Hospital Universitario Salamanca, Salamanca, Spain.
Manuel MirallesDepartment of Surgery, University of Valencia, Valencia, Spain.
Lourdes Del Río-SoláCirugía Vascular, Hospital Universitario de Valladolid, Valladolid, Spain.
Gregorio CastellanosServicio Hematología y Hemoterapia, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
José M MoraledaServicio Hematología y Hemoterapia, Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain.
Robert SacksteinHerbert Wertheim College of Medicine, Florida International University, Miami, FL, United States.
Mariano García-ArranzFundación Jiménez Díaz Health Research Institute, Madrid, Spain.
Damián García-OlmoFundación Jiménez Díaz Health Research Institute, Madrid, Spain.
Franz MartínDepartment of Regeneration and Cell Therapy, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), University of Pablo de Olavide-University of Seville-CSIC, Seville, Spain.
Abdelkrim HmadchaDepartment of Regeneration and Cell Therapy, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), University of Pablo de Olavide-University of Seville-CSIC, Seville, Spain.
Bernat SoriaDepartment of Regeneration and Cell Therapy, Andalusian Center for Molecular Biology and Regenerative Medicine (CABIMER), University of Pablo de Olavide-University of Seville-CSIC, Seville, Spain.
Collaborative Working Group “Noma Project Team”
Centro Andaluz de Biología Molecular y Medicina Regenerativa · ESHospital Universitario Fundación Jiménez Díaz · ESClinica Universidad de Navarra · ESHospital Universitario Virgen de la Arrixaca · ESInstituto de Investigación Biomédica de Salamanca · ESUniversidad Pablo de Olavide · ESCentro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ESFlorida International University · USHospital Central de la Cruz Roja San José y Santa Adela · ESHospital Clínico Universitario de Valladolid · ESHospital Universitario Virgen Macarena · ESUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fimmu.2019.01151.].

Indexed as

cell-based therapycellular medicamentsclinical trialscost-effectivecritical limb ischemiadiabetes

Identifiers

PMID32983148
PMCPMC7492973
OpenAlexW3081942224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.